Literature DB >> 12710686

VHL and kidney cancer.

Michael Ohh1, William G Kaelin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12710686     DOI: 10.1385/1-59259-328-3:167

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


× No keyword cloud information.
  11 in total

1.  VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail.

Authors:  Andrew J Evans; Ryan C Russell; Olga Roche; T Nadine Burry; Jason E Fish; Vinca W K Chow; William Y Kim; Arthy Saravanan; Mindy A Maynard; Michelle L Gervais; Roxana I Sufan; Andrew M Roberts; Leigh A Wilson; Mark Betten; Cindy Vandewalle; Geert Berx; Philip A Marsden; Meredith S Irwin; Bin T Teh; Michael A S Jewett; Michael Ohh
Journal:  Mol Cell Biol       Date:  2006-10-23       Impact factor: 4.272

Review 2.  RLIP76 Targeted Therapy for Kidney Cancer.

Authors:  Sharad S Singhal; Jyotsana Singhal; James Figarola; David Horne; Sanjay Awasthi
Journal:  Pharm Res       Date:  2015-05-29       Impact factor: 4.200

Review 3.  Ubiquitin pathway in VHL cancer syndrome.

Authors:  Michael Ohh
Journal:  Neoplasia       Date:  2006-08       Impact factor: 5.715

4.  Role of the NEDD8 modification of Cul2 in the sequential activation of ECV complex.

Authors:  Roxana I Sufan; Michael Ohh
Journal:  Neoplasia       Date:  2006-11       Impact factor: 5.715

Review 5.  Small molecule regulators of Rb-E2F pathway as modulators of transcription.

Authors:  Sandeep Singh; Jackie Johnson; Srikumar Chellappan
Journal:  Biochim Biophys Acta       Date:  2010-07-15

6.  pVHL modification by NEDD8 is required for fibronectin matrix assembly and suppression of tumor development.

Authors:  Natalie H Stickle; Jacky Chung; Jeffery M Klco; Richard P Hill; William G Kaelin; Michael Ohh
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

7.  The E3 ligase C-CBL inhibits cancer cell migration by neddylating the proto-oncogene c-Src.

Authors:  Gun-Woo Lee; Jun Bum Park; Sung Yeon Park; Jieun Seo; Seung-Hyun Shin; Jong-Wan Park; Sang Jung Kim; Masatoshi Watanabe; Yang-Sook Chun
Journal:  Oncogene       Date:  2018-06-13       Impact factor: 9.867

Review 8.  Atlas on substrate recognition subunits of CRL2 E3 ligases.

Authors:  Siwei Wang; Wenjia Xia; Mantang Qiu; Xin Wang; Feng Jiang; Rong Yin; Lin Xu
Journal:  Oncotarget       Date:  2016-07-19

Review 9.  Functional significance of erythropoietin in renal cell carcinoma.

Authors:  Christudas Morais; David W Johnson; David A Vesey; Glenda C Gobe
Journal:  BMC Cancer       Date:  2013-01-10       Impact factor: 4.430

Review 10.  Role of novel histone modifications in cancer.

Authors:  Muthu K Shanmugam; Frank Arfuso; Surendar Arumugam; Arunachalam Chinnathambi; Bian Jinsong; Sudha Warrier; Ling Zhi Wang; Alan Prem Kumar; Kwang Seok Ahn; Gautam Sethi; Manikandan Lakshmanan
Journal:  Oncotarget       Date:  2017-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.